Spearheading one of the top-ranked multinational pharmaceutical companies in Greece, Marcos Gerassopoulos, Country Chair of Sanofi, shares his views on how global Sanofi transformations are translated in Greece, the challenges in the pharmaceutical landscape in the country, and Greek resiliency in the midst of a crisis.
Mr. Gerassopoulos, you have been the General Manager of Sanofi Greece for 12.5 years, assuming the position in the same year that the company merged with Aventis, essentially being responsible for spearheading a newly-formed company. Given this background, how would you describe the evolution of Sanofi’s presence in the Greek market?
"Sanofi’s path for transforming innovations into healthcare solutions fits well in the context of Greece and its circumstances today."
